WWOX and lung carcinoma: The consequent early HR repair of DSBs associated with Wwox absence is significant since it enhances the subsequent resistance to commonly used DNA damaging drugs, such as IR and carboplatin, and confers a survival advantage to Wwox-deficient cells, as we have previously shown for human ovarian and lung cancer patients [6].